Screening, Monitoring, Prevention, and Treatment Strategies for Chronic Kidney Disease in Patients with Type 2 Diabetes

  • Dagogo-Jack S
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetes is a major risk factor for chronic kidney disease (CKD), and an estimated 20–40% of people with diabetes have evidence of CKD (109,201–205). In people with type 1 diabetes, CKD usually develops ≥10 years after diagnosis of diabetes. Because the exact time of onset of type 2 diabetes is often unclear and many patients may have had the condition for several years before diagnosis, CKD can manifest at diagnosis of type 2 diabetes.

Cite

CITATION STYLE

APA

Dagogo-Jack, S. (2021). Screening, Monitoring, Prevention, and Treatment Strategies for Chronic Kidney Disease in Patients with Type 2 Diabetes. ADA Clinical Compendia, 2021(1), 23–27. https://doi.org/10.2337/db20211-23

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free